Hemab Therapeutics Holdings, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| COAG | IRON | QURE | ADMA | DMRA | AGMB | |
|---|---|---|---|---|---|---|
| Market cap | 2.11B | 3.70B | 1.62B | 2.35B | 1.42B | 337.35M |
| P/E (TTM) | — | — | — | 15.0 | — | — |
| Forward P/E | -17.7 | -12.2 | -7.8 | 11.1 | -10.6 | -3.4 |
| Price/book | 4.6 | 5.0 | 7.2 | 5.2 | -0.2 | 2.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +32.62% | −4.28% | −16.28% | −25.30% | +294.16% | −53.24% |
| Today | +4.62% | +2.61% | −3.52% | −5.67% | +3.89% | 0.00% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All COAG news ›Hemab Therapeutics Holdings, Inc.'s (NASDAQ:COAG) Lock-Up Period Will Expire on October 28th
View Our Latest Report on COAG Hemab Therapeutics stock opened at $34.17 on Wednesday. Hemab Therapeutics has a 52 week low of $23.00 and a 52 week high of $55.42. The stock has a 50-day simple moving average of $40.17. The stock has a…
Hemab Therapeutics (NASDAQ:COAG) Stock Price Up 8.4% - Here's What Happened
Hemab Therapeutics Holdings, Inc. (NASDAQ:COAG - Get Free Report)'s stock price shot up 8.4% during trading on Thursday. The stock traded as high as $32.55 and last traded at $32.46. Approximately 136,454 shares changed hands during…
Hemab Therapeutics (NASDAQ:COAG) Stock Rated Overweight in New Coverage at JPMorgan Chase & Co.
Equities research analysts at JPMorgan Chase & Co. assumed coverage on shares of Hemab Therapeutics (NASDAQ:COAG - Get Free Report) in a research note issued on Thursday, Briefing.com reports. The firm set an "overweight" rating and a…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketbeat.com4
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.